
Compounding Pharmacy Industry Research Report 2024
Description
Compounding Pharmacy Industry Research Report 2024
The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:
A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.
A person may be allergic to one of the ingredients in the commercial version of a drug.
A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.
Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.
Highlights
The global Compounding Pharmacy market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Pharmacy.
The Compounding Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla Pharmacy&Stores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Product Type Insights
Global markets are presented by Compounding Pharmacy type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Compounding Pharmacy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Compounding Pharmacy segment by Type
PIA
PAA
CUPM
PDA
SAPM
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Compounding Pharmacy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Compounding Pharmacy market.
Compounding Pharmacy Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Compounding Pharmacy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounding Pharmacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Compounding Pharmacy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Compounding Pharmacy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounding Pharmacy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Compounding Pharmacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
115 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Compounding Pharmacy by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 1.2.2 PIA
- 1.2.3 PAA
- 1.2.4 CUPM
- 1.2.5 PDA
- 1.2.6 SAPM
- 2.3 Compounding Pharmacy by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Consumers Aged 18 and Younger
- 2.3.3 Consumers Aged 19 to 44
- 2.3.4 Consumers Aged 45 to 64
- 2.3.5 Consumers Aged 65 and Older
- 2.4 Assumptions and Limitations
- 3 Compounding Pharmacy Breakdown Data by Type
- 3.1 Global Compounding Pharmacy Historic Market Size by Type (2019-2024)
- 3.2 Global Compounding Pharmacy Forecasted Market Size by Type (2025-2030)
- 4 Compounding Pharmacy Breakdown Data by Application
- 4.1 Global Compounding Pharmacy Historic Market Size by Application (2019-2024)
- 4.2 Global Compounding Pharmacy Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Compounding Pharmacy Market Perspective (2019-2030)
- 5.2 Global Compounding Pharmacy Growth Trends by Region
- 5.2.1 Global Compounding Pharmacy Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Compounding Pharmacy Historic Market Size by Region (2019-2024)
- 5.2.3 Compounding Pharmacy Forecasted Market Size by Region (2025-2030)
- 5.3 Compounding Pharmacy Market Dynamics
- 5.3.1 Compounding Pharmacy Industry Trends
- 5.3.2 Compounding Pharmacy Market Drivers
- 5.3.3 Compounding Pharmacy Market Challenges
- 5.3.4 Compounding Pharmacy Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Compounding Pharmacy Players by Revenue
- 6.1.1 Global Top Compounding Pharmacy Players by Revenue (2019-2024)
- 6.1.2 Global Compounding Pharmacy Revenue Market Share by Players (2019-2024)
- 6.2 Global Compounding Pharmacy Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Compounding Pharmacy Head office and Area Served
- 6.4 Global Compounding Pharmacy Players, Product Type & Application
- 6.5 Global Compounding Pharmacy Players, Date of Enter into This Industry
- 6.6 Global Compounding Pharmacy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Compounding Pharmacy Market Size (2019-2030)
- 7.2 North America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Compounding Pharmacy Market Size by Country (2019-2024)
- 7.4 North America Compounding Pharmacy Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Compounding Pharmacy Market Size (2019-2030)
- 8.2 Europe Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Compounding Pharmacy Market Size by Country (2019-2024)
- 8.4 Europe Compounding Pharmacy Market Size by Country (2025-2030)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Compounding Pharmacy Market Size (2019-2030)
- 9.2 Asia-Pacific Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Compounding Pharmacy Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Compounding Pharmacy Market Size by Country (2025-2030)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Compounding Pharmacy Market Size (2019-2030)
- 10.2 Latin America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Compounding Pharmacy Market Size by Country (2019-2024)
- 10.4 Latin America Compounding Pharmacy Market Size by Country (2025-2030)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Compounding Pharmacy Market Size (2019-2030)
- 11.2 Middle East & Africa Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Compounding Pharmacy Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Compounding Pharmacy Market Size by Country (2025-2030)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 PharMEDium Services
- 11.1.1 PharMEDium Services Company Detail
- 11.1.2 PharMEDium Services Business Overview
- 11.1.3 PharMEDium Services Compounding Pharmacy Introduction
- 11.1.4 PharMEDium Services Revenue in Compounding Pharmacy Business (2017-2022)
- 11.1.5 PharMEDium Services Recent Development
- 11.2 B. Braun Group
- 11.2.1 B. Braun Group Company Detail
- 11.2.2 B. Braun Group Business Overview
- 11.2.3 B. Braun Group Compounding Pharmacy Introduction
- 11.2.4 B. Braun Group Revenue in Compounding Pharmacy Business (2017-2022)
- 11.2.5 B. Braun Group Recent Development
- 11.3 Fagron
- 11.3.1 Fagron Company Detail
- 11.3.2 Fagron Business Overview
- 11.3.3 Fagron Compounding Pharmacy Introduction
- 11.3.4 Fagron Revenue in Compounding Pharmacy Business (2017-2022)
- 11.3.5 Fagron Recent Development
- 11.4 Wedgewood Pharmacy
- 11.4.1 Wedgewood Pharmacy Company Detail
- 11.4.2 Wedgewood Pharmacy Business Overview
- 11.4.3 Wedgewood Pharmacy Compounding Pharmacy Introduction
- 11.4.4 Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.4.5 Wedgewood Pharmacy Recent Development
- 11.5 New Compounding Pharma
- 11.5.1 New Compounding Pharma Company Detail
- 11.5.2 New Compounding Pharma Business Overview
- 11.5.3 New Compounding Pharma Compounding Pharmacy Introduction
- 11.5.4 New Compounding Pharma Revenue in Compounding Pharmacy Business (2017-2022)
- 11.5.5 New Compounding Pharma Recent Development
- 11.6 Medisca
- 11.6.1 Medisca Company Detail
- 11.6.2 Medisca Business Overview
- 11.6.3 Medisca Compounding Pharmacy Introduction
- 11.6.4 Medisca Revenue in Compounding Pharmacy Business (2017-2022)
- 11.6.5 Medisca Recent Development
- 11.7 Fresenius Kabi
- 11.7.1 Fresenius Kabi Company Detail
- 11.7.2 Fresenius Kabi Business Overview
- 11.7.3 Fresenius Kabi Compounding Pharmacy Introduction
- 11.7.4 Fresenius Kabi Revenue in Compounding Pharmacy Business (2017-2022)
- 11.7.5 Fresenius Kabi Recent Development
- 11.8 Advanced Pharma
- 11.8.1 Advanced Pharma Company Detail
- 11.8.2 Advanced Pharma Business Overview
- 11.8.3 Advanced Pharma Compounding Pharmacy Introduction
- 11.8.4 Advanced Pharma Revenue in Compounding Pharmacy Business (2017-2022)
- 11.8.5 Advanced Pharma Recent Development
- 11.9 AIN GROUP
- 11.9.1 AIN GROUP Company Detail
- 11.9.2 AIN GROUP Business Overview
- 11.9.3 AIN GROUP Compounding Pharmacy Introduction
- 11.9.4 AIN GROUP Revenue in Compounding Pharmacy Business (2017-2022)
- 11.9.5 AIN GROUP Recent Development
- 11.10 Nihon Chouzai
- 11.10.1 Nihon Chouzai Company Detail
- 11.10.2 Nihon Chouzai Business Overview
- 11.10.3 Nihon Chouzai Compounding Pharmacy Introduction
- 11.10.4 Nihon Chouzai Revenue in Compounding Pharmacy Business (2017-2022)
- 11.10.5 Nihon Chouzai Recent Development
- 11.11 Sogo Medical
- 11.11.1 Sogo Medical Company Detail
- 11.11.2 Sogo Medical Business Overview
- 11.11.3 Sogo Medical Compounding Pharmacy Introduction
- 11.11.4 Sogo Medical Revenue in Compounding Pharmacy Business (2017-2022)
- 11.11.5 Sogo Medical Recent Development
- 11.12 Dougherty’s Pharmacy
- 11.12.1 Dougherty’s Pharmacy Company Detail
- 11.12.2 Dougherty’s Pharmacy Business Overview
- 11.12.3 Dougherty’s Pharmacy Compounding Pharmacy Introduction
- 11.12.4 Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.12.5 Dougherty’s Pharmacy Recent Development
- 11.13 Apollo Pharmacy
- 11.13.1 Apollo Pharmacy Company Detail
- 11.13.2 Apollo Pharmacy Business Overview
- 11.13.3 Apollo Pharmacy Compounding Pharmacy Introduction
- 11.13.4 Apollo Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.13.5 Apollo Pharmacy Recent Development
- 11.14 Downing Labs
- 11.14.1 Downing Labs Company Detail
- 11.14.2 Downing Labs Business Overview
- 11.14.3 Downing Labs Compounding Pharmacy Introduction
- 11.14.4 Downing Labs Revenue in Compounding Pharmacy Business (2017-2022)
- 11.14.5 Downing Labs Recent Development
- 11.15 Qol Holdings
- 11.15.1 Qol Holdings Company Detail
- 11.15.2 Qol Holdings Business Overview
- 11.15.3 Qol Holdings Compounding Pharmacy Introduction
- 11.15.4 Qol Holdings Revenue in Compounding Pharmacy Business (2017-2022)
- 11.15.5 Qol Holdings Recent Development
- 11.16 Olympia Pharmacy
- 11.16.1 Olympia Pharmacy Company Detail
- 11.16.2 Olympia Pharmacy Business Overview
- 11.16.3 Olympia Pharmacy Compounding Pharmacy Introduction
- 11.16.4 Olympia Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.16.5 Olympia Pharmacy Recent Development
- 11.17 PUMCH
- 11.17.1 PUMCH Company Detail
- 11.17.2 PUMCH Business Overview
- 11.17.3 PUMCH Compounding Pharmacy Introduction
- 11.17.4 PUMCH Revenue in Compounding Pharmacy Business (2017-2022)
- 11.17.5 PUMCH Recent Development
- 11.18 Triangle Compounding Pharmacy
- 11.18.1 Triangle Compounding Pharmacy Company Detail
- 11.18.2 Triangle Compounding Pharmacy Business Overview
- 11.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Introduction
- 11.18.4 Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.18.5 Triangle Compounding Pharmacy Recent Development
- 11.19 Peking University First Hospital
- 11.19.1 Peking University First Hospital Company Detail
- 11.19.2 Peking University First Hospital Business Overview
- 11.19.3 Peking University First Hospital Compounding Pharmacy Introduction
- 11.19.4 Peking University First Hospital Revenue in Compounding Pharmacy Business (2017-2022)
- 11.19.5 Peking University First Hospital Recent Development
- 11.20 Affiliated Hospital of Guangdong Public Institution of Medicine
- 11.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Detail
- 11.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
- 11.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Introduction
- 11.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2017-2022)
- 11.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
- 11.21 Lorraine's Pharmacy
- 11.21.1 Lorraine's Pharmacy Company Detail
- 11.21.2 Lorraine's Pharmacy Business Overview
- 11.21.3 Lorraine's Pharmacy Compounding Pharmacy Introduction
- 11.21.4 Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.21.5 Lorraine's Pharmacy Recent Development
- 11.22 PLAGH
- 11.22.1 PLAGH Company Detail
- 11.22.2 PLAGH Business Overview
- 11.22.3 PLAGH Compounding Pharmacy Introduction
- 11.22.4 PLAGH Revenue in Compounding Pharmacy Business (2017-2022)
- 11.22.5 PLAGH Recent Development
- 11.23 Institutional Pharmacy Solutions
- 11.23.1 Institutional Pharmacy Solutions Company Detail
- 11.23.2 Institutional Pharmacy Solutions Business Overview
- 11.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Introduction
- 11.23.4 Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2017-2022)
- 11.23.5 Institutional Pharmacy Solutions Recent Development
- 11.24 Ruijin Hospital
- 11.24.1 Ruijin Hospital Company Detail
- 11.24.2 Ruijin Hospital Business Overview
- 11.24.3 Ruijin Hospital Compounding Pharmacy Introduction
- 11.24.4 Ruijin Hospital Revenue in Compounding Pharmacy Business (2017-2022)
- 11.24.5 Ruijin Hospital Recent Development
- 11.25 Belle Sante
- 11.25.1 Belle Sante Company Detail
- 11.25.2 Belle Sante Business Overview
- 11.25.3 Belle Sante Compounding Pharmacy Introduction
- 11.25.4 Belle Sante Revenue in Compounding Pharmacy Business (2017-2022)
- 11.25.5 Belle Sante Recent Development
- 11.26 Byculla Pharmacy&Stores
- 11.26.1 Byculla Pharmacy&Stores Company Detail
- 11.26.2 Byculla Pharmacy&Stores Business Overview
- 11.26.3 Byculla Pharmacy&Stores Compounding Pharmacy Introduction
- 11.26.4 Byculla Pharmacy&Stores Revenue in Compounding Pharmacy Business (2017-2022)
- 11.26.5 Byculla Pharmacy&Stores Recent Development
- 11.27 Royal Chemists
- 11.27.1 Royal Chemists Company Detail
- 11.27.2 Royal Chemists Business Overview
- 11.27.3 Royal Chemists Compounding Pharmacy Introduction
- 11.27.4 Royal Chemists Revenue in Compounding Pharmacy Business (2017-2022)
- 11.27.5 Royal Chemists Recent Development
- 11.28 Village Compounding Pharmacy
- 11.28.1 Village Compounding Pharmacy Company Detail
- 11.28.2 Village Compounding Pharmacy Business Overview
- 11.28.3 Village Compounding Pharmacy Compounding Pharmacy Introduction
- 11.28.4 Village Compounding Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.28.5 Village Compounding Pharmacy Recent Development
- 11.29 Specialist Pharmacy
- 11.29.1 Specialist Pharmacy Company Detail
- 11.29.2 Specialist Pharmacy Business Overview
- 11.29.3 Specialist Pharmacy Compounding Pharmacy Introduction
- 11.29.4 Specialist Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
- 11.29.5 Specialist Pharmacy Recent Development
- 13 Report Conclusion
- 14 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
- Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
- Table 5. Global Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
- Table 6. Global Compounding Pharmacy Revenue Market Share by Type (2019-2024)
- Table 7. Global Compounding Pharmacy Forecasted Market Size by Type (2025-2030) & (US$ Million)
- Table 8. Global Compounding Pharmacy Revenue Market Share by Type (2025-2030)
- Table 9. Global Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
- Table 10. Global Compounding Pharmacy Revenue Market Share by Application (2019-2024)
- Table 11. Global Compounding Pharmacy Forecasted Market Size by Application (2025-2030) & (US$ Million)
- Table 12. Global Compounding Pharmacy Revenue Market Share by Application (2025-2030)
- Table 13. Global Compounding Pharmacy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
- Table 14. Global Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
- Table 15. Global Compounding Pharmacy Market Share by Region (2019-2024)
- Table 16. Global Compounding Pharmacy Forecasted Market Size by Region (2025-2030) & (US$ Million)
- Table 17. Global Compounding Pharmacy Market Share by Region (2025-2030)
- Table 18. Compounding Pharmacy Market Trends
- Table 19. Compounding Pharmacy Market Drivers
- Table 20. Compounding Pharmacy Market Challenges
- Table 21. Compounding Pharmacy Market Restraints
- Table 22. Global Top Compounding Pharmacy Manufacturers by Revenue (US$ Million) & (2019-2024)
- Table 23. Global Compounding Pharmacy Revenue Market Share by Manufacturers (2019-2024)
- Table 24. Global Compounding Pharmacy Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
- Table 25. Global Key Players of Compounding Pharmacy, Headquarters and Area Served
- Table 26. Global Compounding Pharmacy Manufacturers, Product Type & Application
- Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 28. Global Compounding Pharmacy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
- Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
- Table 30. North America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 31. North America Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
- Table 32. North America Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
- Table 33. Europe Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 34. Europe Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
- Table 35. Europe Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
- Table 36. Asia-Pacific Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 37. Asia-Pacific Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
- Table 38. Asia-Pacific Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
- Table 39. Latin America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 40. Latin America Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
- Table 41. Latin America Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
- Table 42. Middle East & Africa Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 43. Middle East & Africa Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
- Table 44. Middle East & Africa Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
- Table 45. PharMEDium Services Company Detail
- Table 46. PharMEDium Services Business Overview
- Table 47. PharMEDium Services Compounding Pharmacy Product
- Table 48. PharMEDium Services Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 49. PharMEDium Services Recent Development
- Table 50. B. Braun Group Company Detail
- Table 51. B. Braun Group Business Overview
- Table 52. B. Braun Group Compounding Pharmacy Product
- Table 53. B. Braun Group Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 54. B. Braun Group Recent Development
- Table 55. Fagron Company Detail
- Table 56. Fagron Business Overview
- Table 57. Fagron Compounding Pharmacy Product
- Table 58. Fagron Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 59. Fagron Recent Development
- Table 60. Wedgewood Pharmacy Company Detail
- Table 61. Wedgewood Pharmacy Business Overview
- Table 62. Wedgewood Pharmacy Compounding Pharmacy Product
- Table 63. Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 64. Wedgewood Pharmacy Recent Development
- Table 65. New Compounding Pharma Company Detail
- Table 66. New Compounding Pharma Business Overview
- Table 67. New Compounding Pharma Compounding Pharmacy Product
- Table 68. New Compounding Pharma Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 69. New Compounding Pharma Recent Development
- Table 70. Medisca Company Detail
- Table 71. Medisca Business Overview
- Table 72. Medisca Compounding Pharmacy Product
- Table 73. Medisca Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 74. Medisca Recent Development
- Table 75. Fresenius Kabi Company Detail
- Table 76. Fresenius Kabi Business Overview
- Table 77. Fresenius Kabi Compounding Pharmacy Product
- Table 78. Fresenius Kabi Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 79. Fresenius Kabi Recent Development
- Table 80. Advanced Pharma Company Detail
- Table 81. Advanced Pharma Business Overview
- Table 82. Advanced Pharma Compounding Pharmacy Product
- Table 83. Advanced Pharma Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 84. Advanced Pharma Recent Development
- Table 85. AIN GROUP Company Detail
- Table 86. AIN GROUP Business Overview
- Table 87. AIN GROUP Compounding Pharmacy Product
- Table 88. AIN GROUP Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 89. AIN GROUP Recent Development
- Table 90. Nihon Chouzai Company Detail
- Table 91. Nihon Chouzai Business Overview
- Table 92. Nihon Chouzai Compounding Pharmacy Product
- Table 93. Nihon Chouzai Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 94. Nihon Chouzai Recent Development
- Table 95. Sogo Medical Company Detail
- Table 96. Sogo Medical Business Overview
- Table 97. Sogo Medical Compounding PharmacyProduct
- Table 98. Sogo Medical Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 99. Sogo Medical Recent Development
- Table 100. Dougherty’s Pharmacy Company Detail
- Table 101. Dougherty’s Pharmacy Business Overview
- Table 102. Dougherty’s Pharmacy Compounding PharmacyProduct
- Table 103. Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 104. Dougherty’s Pharmacy Recent Development
- Table 105. Apollo Pharmacy Company Detail
- Table 106. Apollo Pharmacy Business Overview
- Table 107. Apollo Pharmacy Compounding PharmacyProduct
- Table 108. Apollo Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 109. Apollo Pharmacy Recent Development
- Table 110. Downing Labs Company Detail
- Table 111. Downing Labs Business Overview
- Table 112. Downing Labs Compounding PharmacyProduct
- Table 113. Downing Labs Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 114. Downing Labs Recent Development
- Table 115. Qol Holdings Company Detail
- Table 116. Qol Holdings Business Overview
- Table 117. Qol Holdings Compounding PharmacyProduct
- Table 118. Qol Holdings Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 119. Qol Holdings Recent Development
- Table 120. Olympia Pharmacy Company Detail
- Table 121. Olympia Pharmacy Business Overview
- Table 122. Olympia Pharmacy Compounding PharmacyProduct
- Table 123. Olympia Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 124. Olympia Pharmacy Recent Development
- Table 125. PUMCH Company Detail
- Table 126. PUMCH Business Overview
- Table 127. PUMCH Compounding PharmacyProduct
- Table 128. PUMCH Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 129. PUMCH Recent Development
- Table 130. Triangle Compounding Pharmacy Company Detail
- Table 131. Triangle Compounding Pharmacy Business Overview
- Table 132. Triangle Compounding Pharmacy Compounding PharmacyProduct
- Table 133. Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 134. Triangle Compounding Pharmacy Recent Development
- Table 135. Peking University First Hospital Company Detail
- Table 136. Peking University First Hospital Business Overview
- Table 137. Peking University First Hospital Compounding PharmacyProduct
- Table 138. Peking University First Hospital Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 139. Peking University First Hospital Recent Development
- Table 140. Affiliated Hospital of Guangdong Public Institution of Medicine Company Detail
- Table 141. Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
- Table 142. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding PharmacyProduct
- Table 143. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 144. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
- Table 145. Lorraine's Pharmacy Company Detail
- Table 146. Lorraine's Pharmacy Business Overview
- Table 147. Lorraine's Pharmacy Compounding PharmacyProduct
- Table 148. Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 149. Lorraine's Pharmacy Recent Development
- Table 150. PLAGH Company Detail
- Table 151. PLAGH Business Overview
- Table 152. PLAGH Compounding PharmacyProduct
- Table 153. PLAGH Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 154. PLAGH Recent Development
- Table 155. Institutional Pharmacy Solutions Company Detail
- Table 156. Institutional Pharmacy Solutions Business Overview
- Table 157. Institutional Pharmacy Solutions Compounding PharmacyProduct
- Table 158. Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 159. Institutional Pharmacy Solutions Recent Development
- Table 160. Ruijin Hospital Company Detail
- Table 161. Ruijin Hospital Business Overview
- Table 162. Ruijin Hospital Compounding PharmacyProduct
- Table 163. Ruijin Hospital Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 164. Ruijin Hospital Recent Development
- Table 165. Belle Sante Company Detail
- Table 166. Belle Sante Business Overview
- Table 167. Belle Sante Compounding PharmacyProduct
- Table 168. Belle Sante Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 169. Belle Sante Recent Development
- Table 170. Byculla Pharmacy&Stores Company Detail
- Table 171. Byculla Pharmacy&Stores Business Overview
- Table 172. Byculla Pharmacy&Stores Compounding PharmacyProduct
- Table 173. Byculla Pharmacy&Stores Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 174. Byculla Pharmacy&Stores Recent Development
- Table 175. Royal Chemists Company Detail
- Table 176. Royal Chemists Business Overview
- Table 177. Royal Chemists Compounding PharmacyProduct
- Table 178. Royal Chemists Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 179. Royal Chemists Recent Development
- Table 180. Village Compounding Pharmacy Company Detail
- Table 181. Village Compounding Pharmacy Business Overview
- Table 182. Village Compounding Pharmacy Compounding PharmacyProduct
- Table 183. Village Compounding Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 184. Village Compounding Pharmacy Recent Development
- Table 185. Specialist Pharmacy Company Detail
- Table 186. Specialist Pharmacy Business Overview
- Table 187. Specialist Pharmacy Compounding PharmacyProduct
- Table 188. Specialist Pharmacy Revenue in Compounding Pharmacy Business (2017-2022) & (US$ Million)
- Table 189. Specialist Pharmacy Recent Development
- Table 190. PharMEDium Services Company Information
- Table 191. PharMEDium Services Business Overview
- Table 192. PharMEDium Services Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
- Table 193. PharMEDium Services Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million) Portfolio
- Table 194. PharMEDium Services Recent Development
- Table 195. B. Braun Group Company Information
- Table 196. B. Braun Group Business Overview
- Table 197. B. Braun Group Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
- Table 198. B. Braun Group Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million) Portfolio
- Table 199. B. Braun Group Recent Development
- Table 200. Fagron Company Information
- Table 201. Fagron Business Overview
- Table 202. Fagron Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
- Table 203. Fagron Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million) Portfolio
- Table 204. Fagron Recent Development
- Table 205. Wedgewood Pharmacy Company Information
- Table 206. Wedgewood Pharmacy Business Overview
- Table 207. Wedgewood Pharmacy Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
- Table 208. Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million) Portfolio
- Table 209. Wedgewood Pharmacy Recent Development
- Table 210. New Compounding Pharma Company Information
- Table 211. New Compounding Pharma Business Overview
- Table 212. New Compounding Pharma Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
- Table 213. New Compounding Pharma Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million) Portfolio
- Table 214. New Compounding Pharma Recent Development
- Table 215. Medisca Company Information
- Table 216. Medisca Business Overview
- Table 217. Medisca Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.